BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

942 related articles for article (PubMed ID: 17179479)

  • 1. The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.
    Phillips TM; McBride WH; Pajonk F
    J Natl Cancer Inst; 2006 Dec; 98(24):1777-85. PubMed ID: 17179479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Senescence evasion by MCF-7 human breast tumor-initiating cells.
    Karimi-Busheri F; Rasouli-Nia A; Mackey JR; Weinfeld M
    Breast Cancer Res; 2010; 12(3):R31. PubMed ID: 20525204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STAT1 promotes radioresistance of CD44(+)/CD24(-/low) cells in breast cancer.
    Zhan JF; Chen LH; Yuan YW; Xie GZ; Sun AM; Liu Y; Chen ZX
    Exp Biol Med (Maywood); 2011 Apr; 236(4):418-22. PubMed ID: 21444368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody against human Notch1 ligand-binding domain depletes subpopulation of putative breast cancer stem-like cells.
    Sharma A; Paranjape AN; Rangarajan A; Dighe RR
    Mol Cancer Ther; 2012 Jan; 11(1):77-86. PubMed ID: 22075160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
    Calcagno AM; Salcido CD; Gillet JP; Wu CP; Fostel JM; Mumau MD; Gottesman MM; Varticovski L; Ambudkar SV
    J Natl Cancer Inst; 2010 Nov; 102(21):1637-52. PubMed ID: 20935265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.
    Duru N; Fan M; Candas D; Menaa C; Liu HC; Nantajit D; Wen Y; Xiao K; Eldridge A; Chromy BA; Li S; Spitz DR; Lam KS; Wicha MS; Li JJ
    Clin Cancer Res; 2012 Dec; 18(24):6634-47. PubMed ID: 23091114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the stemness potency of
    Yousefnia S; Ghaedi K; Seyed Forootan F; Nasr Esfahani MH
    Tumour Biol; 2019 Aug; 41(8):1010428319869101. PubMed ID: 31423948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic characterization of mammosphere-forming cells from the human MA-11 breast carcinoma cell line.
    Rappa G; Lorico A
    Exp Cell Res; 2010 May; 316(9):1576-86. PubMed ID: 20074564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
    So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
    J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of normothermic microwave irradiation on CD44
    Asano M; Tanaka S; Sakaguchi M
    Biosci Biotechnol Biochem; 2020 Jan; 84(1):103-110. PubMed ID: 31559912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Influence factors on the formation of mammospheres from breast cancer stem cells].
    Huang MZ; Zhang FC; Zhang YY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Oct; 40(5):500-4. PubMed ID: 18931713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.
    Storci G; Sansone P; Mari S; D'Uva G; Tavolari S; Guarnieri T; Taffurelli M; Ceccarelli C; Santini D; Chieco P; Marcu KB; Bonafè M
    J Cell Physiol; 2010 Nov; 225(3):682-91. PubMed ID: 20509143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression analysis of mammospheres cultured from human breast cancers.
    Feifei N; Mingzhi Z; Yanyun Z; Huanle Z; Fang R; Mingzhu H; Mingzhi C; Yafei S; Fengchun Z
    J Cancer Res Clin Oncol; 2012 Nov; 138(11):1937-44. PubMed ID: 22752669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-induced Notch signaling in breast cancer stem cells.
    Lagadec C; Vlashi E; Alhiyari Y; Phillips TM; Bochkur Dratver M; Pajonk F
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):609-18. PubMed ID: 23992604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
    Mine T; Matsueda S; Li Y; Tokumitsu H; Gao H; Danes C; Wong KK; Wang X; Ferrone S; Ioannides CG
    Cancer Immunol Immunother; 2009 Aug; 58(8):1185-94. PubMed ID: 19048252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammary stem cells and breast cancer--role of Notch signalling.
    Farnie G; Clarke RB
    Stem Cell Rev; 2007 Jun; 3(2):169-75. PubMed ID: 17873349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of curcumin on the cell surface markers CD44 and CD24 in breast cancer.
    Calaf GM; Ponce-Cusi R; Abarca-Quinones J
    Oncol Rep; 2018 Jun; 39(6):2741-2748. PubMed ID: 29693159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD44, CD24 and ESA in pancreatic adenocarcinoma cell lines varies with local microenvironment.
    Wei HJ; Yin T; Zhu Z; Shi PF; Tian Y; Wang CY
    Hepatobiliary Pancreat Dis Int; 2011 Aug; 10(4):428-34. PubMed ID: 21813394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
    Wang J; Gildea JJ; Yue W
    Oncogene; 2013 Oct; 32(44):5233-40. PubMed ID: 23178495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.